MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.028
+0.018 (1.77%)
Apr 29, 2026, 11:34 AM EDT - Market open
MIRA Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 6.35 | 2.83 | 4.6 | 0.35 | 2.81 | Upgrade
|
| Short-Term Investments | 4.68 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 11.03 | 2.83 | 4.6 | 0.35 | 2.81 | Upgrade
|
| Cash Growth | 289.35% | -38.45% | 1211.36% | -87.51% | 80379.86% | Upgrade
|
| Other Receivables | - | - | 0.01 | - | - | Upgrade
|
| Receivables | - | - | 0.01 | - | - | Upgrade
|
| Prepaid Expenses | 0.03 | 0.05 | 0.24 | - | - | Upgrade
|
| Other Current Assets | - | - | - | 0.14 | 0.1 | Upgrade
|
| Total Current Assets | 11.06 | 2.89 | 4.86 | 0.49 | 2.91 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.01 | 0.36 | - | Upgrade
|
| Long-Term Accounts Receivable | - | - | 0.07 | - | - | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | - | - | 0.45 | Upgrade
|
| Total Assets | 11.09 | 2.92 | 4.93 | 0.86 | 3.36 | Upgrade
|
| Accounts Payable | 0.13 | 0.72 | 0.54 | 0.91 | 0.78 | Upgrade
|
| Accrued Expenses | - | - | 0.01 | 0.06 | 0.02 | Upgrade
|
| Short-Term Debt | 0.57 | - | - | 0.13 | 0.29 | Upgrade
|
| Current Portion of Leases | - | - | 0.01 | 0.27 | - | Upgrade
|
| Total Current Liabilities | 0.7 | 0.72 | 0.56 | 1.37 | 1.09 | Upgrade
|
| Long-Term Leases | - | - | - | 0.08 | - | Upgrade
|
| Total Liabilities | 0.7 | 0.72 | 0.56 | 1.45 | 1.09 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 49.97 | 31.34 | 25.66 | 8.7 | 4.5 | Upgrade
|
| Retained Earnings | -39.58 | -29.14 | -21.29 | -9.3 | -2.24 | Upgrade
|
| Shareholders' Equity | 10.39 | 2.2 | 4.37 | -0.6 | 2.26 | Upgrade
|
| Total Liabilities & Equity | 11.09 | 2.92 | 4.93 | 0.86 | 3.36 | Upgrade
|
| Total Debt | 0.57 | - | 0.01 | 0.49 | 0.29 | Upgrade
|
| Net Cash (Debt) | 10.46 | 2.83 | 4.6 | -0.14 | 2.52 | Upgrade
|
| Net Cash Growth | 269.13% | -38.38% | - | - | - | Upgrade
|
| Net Cash Per Share | 0.44 | 0.18 | 0.33 | -0.01 | 0.20 | Upgrade
|
| Filing Date Shares Outstanding | 42.02 | 16.81 | 14.78 | 13.31 | 12.67 | Upgrade
|
| Total Common Shares Outstanding | 41.94 | 16.56 | 14.78 | 13.31 | 12.67 | Upgrade
|
| Working Capital | 10.36 | 2.16 | 4.3 | -0.88 | 1.82 | Upgrade
|
| Book Value Per Share | 0.25 | 0.13 | 0.30 | -0.04 | 0.18 | Upgrade
|
| Tangible Book Value | 10.39 | 2.2 | 4.37 | -0.6 | 2.26 | Upgrade
|
| Tangible Book Value Per Share | 0.25 | 0.13 | 0.30 | -0.04 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.